Daily non-political popular news in brief.

Virtual human in HIV drug simulation

The combined supercomputing power of the UK and US 'national grids' has enabled UCL scientists to simulate the efficacy of an HIV drug in blocking a key protein used by the lethal virus. The method -- an early example of the Virtual Physiological Human in action -- could one day be used to tailor personal drug treatments, for example for HIV patients developing resistance to their drugs.

Read more »

Keywords: virtual, human, hiv, drug, simulation

« Previous | Next »

Similar news on "Virtual human in HIV drug simulation":

1. Anti-parasite drug may provide new way to attack HIV
   01-31-2008 · EurekAlert!
   A drug already used to treat parasitic infections, and once looked at for cancer, also attacks the human immunodeficiency virus in a new and powerful way, according to research published today online in the open access journal Retrovirology.
   Similar news · Read more »
   
2. Researchers reveal HIV peptide's possible pathway into the cell
   01-17-2008 · EurekAlert!
   Two theoretical physicists at Rensselaer Polytechnic Institute have uncovered what they believe is the long-sought-after pathway that an HIV peptide takes to enter healthy cells. The theorists analyzed two years of biocomputation and simulation to uncover a surprisingly simple mechanism describing how this protein fragment penetrates the cell membrane. The discovery could help scientists treat other human illnesses by exploiting the same molecules that make HIV so deadly proficient.
   Similar news · Read more »
   
3. Simulation in a virtual combat environment puts surgical skills to the test
   10-16-2006 · EurekAlert!
   A unique study by human factors/ergonomics researchers in Norfolk, Va., concluded that virtual reality-based simulators can provide a safe venue for training military medical personnel in high-stress, high-workload conditions such as combat.
   Similar news · Read more »
   
4. Discovery of an HIV inhibitor in human blood points to new drug class
   04-19-2007 · EurekAlert!
   A new study has pinpointed a natural ingredient of human blood that effectively blocks HIV-1, the virus predominantly responsible for human AIDS, from infecting immune cells and multiplying. The virus blocker might play a role in the progression of HIV to full-blown AIDS and -- because it works in a different way than existing antiretroviral inhibitors -- could lead to the development of another class of drugs in the fight against the pandemic disease.
   Similar news · Read more »
   
5. Gene Signatures Match Cancer And Other Diseases With Potentially Effective Drugs
   09-29-2006 · ScienceDaily
   In one of the most ambitious spinoffs of the human genome project, researchers at Dana-Farber Cancer Institute, Children's Hospital Boston, the Broad Institute of Harvard and MIT, and other collaborating centers have unveiled a new, systematic approach to drug discovery that matches diseases with potential treatments using a universal language based on cells' distinctive gene activity profiles, or "signatures."
   Similar news · Read more »
   
6. Proteochemometrics achieves better retardants for HIV/Aids
   03-14-2007 · EurekAlert!
   A new method for analysis of retroviral proteins gives new opportunities to the development of novel retardants for HIV/Aids. The study, which was published in the March issue of PLoS Computational Biology, shows how to in a very exact way analyze the interaction of drug targets with small molecules.
   Similar news · Read more »
   
7. Drugs users are increasingly more cautious with needles
   05-14-2007 · EurekAlert!
   Even though HIV can be well treated these days, drug users are still more cautious about using needles than they used to be. That is the conclusion of Colette Smit following her study into 25 years of HIV in the Netherlands.
   Similar news · Read more »
   
8. New treatment model for HIV
   07-12-2007 · EurekAlert!
   In this study, clinical responses to antiretroviral drug therapy are simulated for the first time, and the model is then applied to IM therapy.
   Similar news · Read more »
   
9. MIT: 'Micro' livers could aid drug screening
   11-18-2007 · EurekAlert!
   MIT researchers have devised a novel way to create tiny colonies of living human liver cells that model the full-sized organ. The work could allow better screening of new drugs that are potentially harmful to the liver and reduce the costs associated with their development.
   Similar news · Read more »
   
10. World AIDS Day: HIV prevention, diagnosis and treatment
    11-30-2007 · EurekAlert!
    On December 1, PLoS Medicine is publishing a collection of research articles and commentary, as well as an editorial to mark World AIDS Day 2007. In this release: Men who have sex with men face high AIDS risk in developing countries; Women disclose their HIV status at three key times around childbirth; Unnoticed mutation in AIDS virus can cause drug resistance; and HIV confirmatory test can also estimate recent infections.
    Similar news · Read more »